Literature DB >> 26393117

A Study on Atherogenic Indices of Pregnancy Induced Hypertension Patients as Compared to Normal Pregnant Women.

Meenakshi Singh1, Mauchumi Saikia Pathak2, Anindita Paul3.   

Abstract

INTRODUCTION: Pregnancy induced hypertension (PIH) includes Gestational hypertension, Pre-eclampsia and Eclampsia and is one of the most common obstetric complication. Worldwide about 76,000 pregnant women die each year from pre-eclampsia and related hypertensive disorders. The aetiology of Pre-eclampsia is unknown but it is thought to be related to abnormal development of placenta. Several studies have shown the presence of reduced endothelial function in pre-eclamptic pregnancy. Endothelial dysfunction is also a feature of atherosclerosis. AIM: To assess fasting lipid profile and atherogenic indices in women diagnosed with pre-eclampsia as well as in women with normal pregnancy and to correlate the findings of pre-eclamptic women with that of normal pregnant women, in an attempt to utilize the data for the development of a new clinical approach for early recognition and prevention of risk of future cardiovascular diseases in women with PIH.
MATERIALS AND METHODS: This case-control study was conducted on 50 pre-eclampsia patients who were in third trimester of pregnancy (Case group). A control group of 50 age and gestational age matched normal pregnant women was taken. Strict inclusion and exclusion criteria were followed. Fasting Lipid profile parameters were assessed and used to calculate the atherogenic indices namely Atherogenic index of plasma (AIP), Cardiac risk ratio (CRR) and Atherogenic coefficient (AC). Statistical Analysis was done by using student's t-test. Mann-Whitney U-test was used wherever applicable and correlations between the variables were estimated by Pearson's correlation coefficients.
RESULTS: There was an extremely significant (p<0.0001) increase in Atherogenic indices (AIP, CRR and AC) in case group as compared to the control group. A positive and significant correlation of systolic blood pressure with AIP (r=0.3583), CRR (r=0.3137), AC (r=0.3193) was found in cases. There was a positive and significant correlation between gestational age and atherogenic indices in the case group.
CONCLUSION: Women with pre-eclampsia present abnormalities in lipid profile and these lipids turn out to be a risk factor for cardiovascular complications. Evaluation of the atherogenic indices during pregnancy may help prevent this risk.

Entities:  

Keywords:  Atherogenic coefficient; Atherogenic index of plasma; Cardiac coefficient; Lipid profile; Pre-eclampsia

Year:  2015        PMID: 26393117      PMCID: PMC4572947          DOI: 10.7860/JCDR/2015/13505.6241

Source DB:  PubMed          Journal:  J Clin Diagn Res        ISSN: 0973-709X


  21 in total

1.  Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report.

Authors: 
Journal:  Circulation       Date:  2002-12-17       Impact factor: 29.690

2.  Study of lipid profile, lipid peroxidation and vitamin E in pregnancy induced hypertension.

Authors:  Suchanda Sahu; Rebecca Abraham; R Vedavalli; Mary Daniel
Journal:  Indian J Physiol Pharmacol       Date:  2009 Oct-Dec

3.  Impaired vascular dilatation in women with a history of pre-eclampsia.

Authors:  Katja H Lampinen; Mats Rönnback; Risto J Kaaja; Per-Henrik Groop
Journal:  J Hypertens       Date:  2006-04       Impact factor: 4.844

4.  The plasma parameter log (TG/HDL-C) as an atherogenic index: correlation with lipoprotein particle size and esterification rate in apoB-lipoprotein-depleted plasma (FER(HDL)).

Authors:  M Dobiásová; J Frohlich
Journal:  Clin Biochem       Date:  2001-10       Impact factor: 3.281

5.  Atherogenic index of plasma as useful predictor of cardiovascular risk among postmenopausal women in Enugu, Nigeria.

Authors:  U I Nwagha; E J Ikekpeazu; F E Ejezie; E E Neboh; I C Maduka
Journal:  Afr Health Sci       Date:  2010-09       Impact factor: 0.927

6.  Microvascular dysfunction: a link between pre-eclampsia and maternal coronary heart disease.

Authors:  Jane E Ramsay; Frances Stewart; Ian A Greer; Naveed Sattar
Journal:  BJOG       Date:  2003-11       Impact factor: 6.531

7.  Antioxidant activity and lipid peroxidation in preeclampsia.

Authors:  Usha Adiga; Vivian D'souza; Asha Kamath; Nandini Mangalore
Journal:  J Chin Med Assoc       Date:  2007-10       Impact factor: 2.743

Review 8.  Pre-eclampsia and risk of cardiovascular disease and cancer in later life: systematic review and meta-analysis.

Authors:  Leanne Bellamy; Juan-Pablo Casas; Aroon D Hingorani; David J Williams
Journal:  BMJ       Date:  2007-11-01

Review 9.  Does increased oxidative stress cause hypertension?

Authors:  Ehud Grossman
Journal:  Diabetes Care       Date:  2008-02       Impact factor: 19.112

10.  Menopause and metabolic syndrome: A study of 498 urban women from western India.

Authors:  Shefali Pandey; Manisha Srinivas; Shubhada Agashe; Jayashree Joshi; Priti Galvankar; C P Prakasam; Rama Vaidya
Journal:  J Midlife Health       Date:  2010-07
View more
  11 in total

1.  Impact of clinical pharmacists intervention on management of hyperglycemia in pregnancy in Jordan.

Authors:  Razan Adnan Batta; Violet Kasabri; Amal Akour; Dana Hyassat; Abla Albsoul-Younes
Journal:  Int J Clin Pharm       Date:  2017-11-14

2.  Antepartum and postpartum changes in adipokines, endothelial dysfunction, inflammatory markers and other biochemical parameters in preeclamptic women: A prospective observational cohort study.

Authors:  Amany Yasseen Talab; Haitham Aboali Hamza; Tarek Mohamed Mostafa
Journal:  J Appl Biomed       Date:  2021-01-28       Impact factor: 1.797

3.  The Relationship between Angiogenic Factors and Energy Metabolism in Preeclampsia.

Authors:  Alejandra Abascal-Saiz; Marta Duque-Alcorta; Victoria Fioravantti; Eugenia Antolín; Eva Fuente-Luelmo; María Haro; María P Ramos-Álvarez; Germán Perdomo; José L Bartha
Journal:  Nutrients       Date:  2022-05-23       Impact factor: 6.706

4.  ATHEROGENIC INDICES IN THE ASSESSMENT OF CARDIOVASCULAR DISEASE RISK IN CHILDREN WITH OBESITY AND SUBCLINICAL HYPOTHYROIDISM.

Authors:  N Akici; Z E Onal; T Gürbüz; C Sağ; S Kilinç
Journal:  Acta Endocrinol (Buchar)       Date:  2020 Jul-Sep       Impact factor: 0.877

5.  Parity and serum lipid levels: a cross-sectional study in chinese female adults.

Authors:  Haichen Lv; Xiaolei Yang; Yong Zhou; Jing Wu; Henghui Liu; Youxin Wang; Yuanming Pan; Yunlong Xia
Journal:  Sci Rep       Date:  2016-09-20       Impact factor: 4.379

6.  Relationship between Atherogenic Indices and Carotid Intima-Media Thickness in Prediabetes: A Cross-Sectional Study from Central India.

Authors:  Roshan Kumar Mahat; Neelima Singh; Vedika Rathore; Akshara Gupta; Rakesh Kumar Shah
Journal:  Med Sci (Basel)       Date:  2018-07-05

7.  Atherosclerosis risk assessment in patients with chronic obstructive pulmonary disease: a case-control study.

Authors:  Himanshu Sharma; Prem Kapur; Rajinder K Jalali; Kiran Dubey
Journal:  Ther Clin Risk Manag       Date:  2019-08-29       Impact factor: 2.423

8.  Effect of omega-3 supplementation on cardiometabolic indices in diabetic patients with non-alcoholic fatty liver disease: a randomized controlled trial.

Authors:  Abbas Ali Sangouni; Zahra Orang; Hassan Mozaffari-Khosravi
Journal:  BMC Nutr       Date:  2021-12-15

9.  Predictors of Epicardial Fat Volume Decrease after Dapagliflozin Treatment in Patients with Type 2 Diabetes.

Authors:  Adina Braha; Alin Albai; Bogdan Timar; Daniela Cipu; Lucian Vasiluță; Ovidiu Potre; Romulus Timar
Journal:  Medicina (Kaunas)       Date:  2021-12-23       Impact factor: 2.430

10.  Atherogenic Indices Can Predict Atherosclerosis in Patients with Sarcoidosis.

Authors:  Okan Selendili; Ersin Günay; Emre Kaçar; Şule Çilekar; Gürhan Öz; Ahmet Dumanli; Sibel Günay
Journal:  Sarcoidosis Vasc Diffuse Lung Dis       Date:  2022-01-13       Impact factor: 1.803

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.